Date: 27-Aug-2019

AstraZeneca and FibroGens roxadustat, not yet filed in U.S., nabs 2nd anemia nod in China

FibroGen has not even filed its AstraZeneca-partnered oral anemia drug roxadustat for U.S. approval. But the collaborators have already scored their second nod for the blockbuster hopeful in China